• LAST PRICE
    30.9900
  • TODAY'S CHANGE (%)
    Trending Down-0.1200 (-0.3857%)
  • Bid / Lots
    20.0000/ 2
  • Ask / Lots
    34.0000/ 4
  • Open / Previous Close
    30.7800 / 31.1100
  • Day Range
    Low 30.0107
    High 32.0000
  • 52 Week Range
    Low 17.7200
    High 37.8900
  • Volume
    151,359
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 31.11
TimeVolumeANAB
09:32 ET572230.18
09:33 ET20031.28
09:35 ET282231.78
09:37 ET89531.54
09:42 ET20031.02
09:44 ET10031
09:48 ET20030.84
09:51 ET10031.045
09:53 ET20030.85
09:57 ET10030.73
10:00 ET80030.965
10:02 ET45330.96
10:04 ET10030.99
10:08 ET235330.81
10:09 ET10030.78
10:13 ET10030.74
10:15 ET26430.88
10:20 ET10030.73
10:22 ET75330.72
10:24 ET10030.49
10:27 ET321830.75
10:29 ET10030.77
10:33 ET10030.77
10:36 ET30031.06
10:38 ET10031.17
10:40 ET30031.235
10:44 ET30031.13
10:45 ET10031.14
10:47 ET30031.23
10:49 ET60031.165
10:51 ET50031.23
10:54 ET40031.215
10:56 ET10031.21
11:00 ET30030.98
11:03 ET30031.105
11:07 ET180031.11
11:09 ET20031.06
11:12 ET10031.05
11:16 ET30030.915
11:20 ET120031.15
11:21 ET10031.235
11:30 ET10031.235
11:32 ET60031.09
11:34 ET52331.15
11:36 ET40031.05
11:39 ET10030.82
11:41 ET10030.95
11:48 ET10030.96
11:52 ET170030.72
11:54 ET10730.72
11:57 ET206030.71
12:01 ET30030.81
12:08 ET10030.8
12:14 ET40030.67
12:17 ET20030.53
12:19 ET10030.575
12:26 ET10030.52
12:28 ET80030.63
12:30 ET20030.695
12:32 ET20030.83
12:33 ET10030.77
12:35 ET10030.855
12:37 ET20030.75
12:44 ET30031.1
12:50 ET20031.18
12:53 ET10031.01
12:55 ET20031.06
12:57 ET10031.05
01:02 ET30031.045
01:08 ET20030.92
01:09 ET30030.94
01:11 ET70030.95
01:15 ET40030.93
01:18 ET10030.91
01:20 ET60030.73
01:22 ET50030.75
01:24 ET50030.75
01:26 ET30030.75
01:27 ET70030.79
01:29 ET60030.68
01:31 ET90030.665
01:33 ET90630.69
01:36 ET80030.69
01:38 ET40030.69
01:40 ET70030.745
01:42 ET130030.66
01:44 ET20030.75
01:45 ET40030.74
01:47 ET30030.74
01:49 ET40030.68
01:51 ET30030.71
01:54 ET30030.7
01:56 ET40030.75
01:58 ET10030.77
02:02 ET10030.75
02:07 ET20030.8
02:20 ET132731.03
02:21 ET30031.1
02:23 ET10031.13
02:27 ET144831
02:38 ET50030.97
02:39 ET10031.02
02:54 ET10030.9
02:56 ET10030.89
02:57 ET30030.89
02:59 ET40030.74
03:01 ET10030.735
03:08 ET20030.79
03:12 ET254030.83
03:17 ET61431
03:19 ET20031.17
03:21 ET10031.16
03:24 ET50031.19
03:26 ET100031.08
03:30 ET109930.98
03:32 ET40031.13
03:33 ET10030.91
03:35 ET91831.06
03:39 ET107831.12
03:42 ET20031.17
03:44 ET10031.329
03:48 ET111431.28
03:50 ET80031.3099
03:51 ET91130.98
03:53 ET50031.085
03:55 ET70731.145
03:57 ET221231.24
04:00 ET3220930.99
Data delayed at least 15 minutes.

Jan 5, 2022

4:05PM ET on Wednesday Jan 05, 2022 by GlobeNewswire

Dec 31, 2021

3:23AM ET on Friday Dec 31, 2021 by MT Newswires

Dec 30, 2021

4:27PM ET on Thursday Dec 30, 2021 by Thomson Reuters

Dec 23, 2021

6:22AM ET on Thursday Dec 23, 2021 by MT Newswires
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesANAB
AnaptysBio Inc
852.5M
100.7x
---
United StatesHRTX
Heron Therapeutics Inc
854.2M
-3.5x
---
United StatesMNKD
MannKind Corp
952.3M
-11.4x
---
United StatesQURE
Uniqure NV
833.0M
2.7x
---
United StatesMGNX
MacroGenics Inc
778.6M
-5.2x
---
United StatesAGEN
Agenus Inc
688.3M
-23.6x
---
As of 2022-01-22

Company Information

AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its product candidates using its antibody discovery technology platform, which is based upon the natural process of antibody generation, known as somatic hypermutation (SHM), and replicates this natural process of antibody generation in vitro. Its product pipeline includes Imsidolimab, ANB030 (Rosnilimab), ANB032, JEMPERLI, GSK4069889 (cobolimab), GSK4074386 and CC-90006. its Imsidolimab is an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of multiple dermatological inflammatory diseases. ANB030 is an antibody that binds PD-1 in an agonistic manner to suppress T cell activity and anti-inflammatory effects in vivo.

Contact Information

Headquarters
10770 WATERIDGE CIRCLE, SUITE 210SAN DIEGO, CA, United States 92121
Phone
858-362-6295
Fax
858-362-6296

Executives

Independent Chairman of the Board
James Topper
President, Chief Executive Officer, Director
Hamza Suria
Chief Financial Officer
Dennis Mulroy
Chief Operating Officer, General Counsel
Eric Loumeau
Chief Medical Officer
Paul Lizzul

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$852.5M
Revenue (TTM)
$122.2M
Shares Outstanding
27.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.25
EPS
$0.31
Book Value
$14.50
P/E Ratio
100.7x
Price/Sales (TTM)
7.0
Price/Cash Flow (TTM)
94.9x
Operating Margin
6.29%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.